- Home
- CRVS vs WNC Comparison
CRVS vs WNC Comparison
Compare CRVS & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- WNC
- Stock Information
- Founded
- CRVS 2014
- WNC 1985
- Country
- CRVS United States
- WNC United States
- Employees
- CRVS N/A
- WNC N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- WNC Construction/Ag Equipment/Trucks
- Sector
- CRVS Health Care
- WNC Industrials
- Exchange
- CRVS Nasdaq
- WNC Nasdaq
- Market Cap
- CRVS 459.0M
- WNC 396.7M
- IPO Year
- CRVS 2016
- WNC 1991
- Fundamental
- Price
- CRVS $7.59
- WNC $8.56
- Analyst Decision
- CRVS Strong Buy
- WNC Hold
- Analyst Count
- CRVS 4
- WNC 1
- Target Price
- CRVS $13.75
- WNC $9.00
- AVG Volume (30 Days)
- CRVS 1.0M
- WNC 412.6K
- Earning Date
- CRVS 11-04-2025
- WNC 10-30-2025
- Dividend Yield
- CRVS N/A
- WNC 3.74%
- EPS Growth
- CRVS N/A
- WNC N/A
- EPS
- CRVS N/A
- WNC N/A
- Revenue
- CRVS N/A
- WNC $1,720,560,000.00
- Revenue This Year
- CRVS N/A
- WNC N/A
- Revenue Next Year
- CRVS N/A
- WNC $17.22
- P/E Ratio
- CRVS N/A
- WNC N/A
- Revenue Growth
- CRVS N/A
- WNC N/A
- 52 Week Low
- CRVS $2.54
- WNC $6.78
- 52 Week High
- CRVS $10.00
- WNC $20.63
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- WNC 35.00
- Support Level
- CRVS $6.81
- WNC $8.75
- Resistance Level
- CRVS $7.96
- WNC $9.10
- Average True Range (ATR)
- CRVS 0.52
- WNC 0.38
- MACD
- CRVS -0.03
- WNC 0.04
- Stochastic Oscillator
- CRVS 67.50
- WNC 37.36
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.